These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30559104)

  • 1. Response to Comment on Bergenstal et al. Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring. Diabetes Care 2018;41:2275-2280.
    Bergenstal RM; Beck RW; Close KL; Grunberger G; Sacks DB; Kowalski A; Brown AS; Heinemann L; Aleppo G; Ryan DB; Riddlesworth TD; Cefalu WT
    Diabetes Care; 2019 Feb; 42(2):e29-e30. PubMed ID: 30559104
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on Bergenstal et al. Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring. Diabetes Care 2018;41:2275-2280.
    Pluchino KM; Wu Y; Silk AD; Yi J; Lias CH
    Diabetes Care; 2019 Feb; 42(2):e28. PubMed ID: 30559103
    [No Abstract]   [Full Text] [Related]  

  • 3. Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring.
    Bergenstal RM; Beck RW; Close KL; Grunberger G; Sacks DB; Kowalski A; Brown AS; Heinemann L; Aleppo G; Ryan DB; Riddlesworth TD; Cefalu WT
    Diabetes Care; 2018 Nov; 41(11):2275-2280. PubMed ID: 30224348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship Between Time-in-Range, HbA1c, and the Glucose Management Indicator in Pregnancies Complicated by Type 1 Diabetes.
    Shah VN; Snell-Bergeon JK; Demmitt JK; Joshee P; Garcetti R; Pyle L; Polsky S
    Diabetes Technol Ther; 2021 Dec; 23(12):783-790. PubMed ID: 34524020
    [No Abstract]   [Full Text] [Related]  

  • 5. Correlation between glucose measurement parameters of continuous flash monitoring and HbA1c. Real life experience in Asturias.
    Pujante Alarcón P; Alonso Felgueroso C; Ares Blanco J; Morales Sánchez P; Lambert Goitia C; Rodríguez Escobedo R; Rodríguez Rodero S; Delgado Alvarez E; Menéndez Torre EL
    Endocrinol Diabetes Nutr (Engl Ed); 2022; 69(7):493-499. PubMed ID: 36028448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycemic Targets and Glucose Monitoring.
    Oser TK; Oser SM
    Prim Care; 2022 Jun; 49(2):213-223. PubMed ID: 35595478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of HbA1c and glucose management indicator discordance in a population of children and adolescents with type 1 diabetes.
    Piona C; Marigliano M; Mozzillo E; Di Candia F; Zanfardino A; Iafusco D; Maltoni G; Zucchini S; Piccinno E; Maffeis C
    Pediatr Diabetes; 2022 Feb; 23(1):84-89. PubMed ID: 34888998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose Management Indicator for People with Type 1 Asian Diabetes Is Different from That of the Published Equation: Differences by Glycated Hemoglobin Distribution.
    Yoo JH; Yang SH; Kim G; Kim JH
    Diabetes Technol Ther; 2021 Nov; 23(11):745-752. PubMed ID: 34160289
    [No Abstract]   [Full Text] [Related]  

  • 9. Comment on "The pros and cons of continuous glucose monitoring for patients with type 1 diabetes on multiple daily injections of insulin.".
    Giulio F; Valeria F; Clara B
    Endocrine; 2018 Jan; 59(1):230. PubMed ID: 28646379
    [No Abstract]   [Full Text] [Related]  

  • 10. The Relationship Between CGM-Derived Metrics, A1C, and Risk of Hypoglycemia in Older Adults With Type 1 Diabetes.
    Toschi E; Slyne C; Sifre K; O'Donnell R; Greenberg J; Atakov-Castillo A; Carl S; Munshi M
    Diabetes Care; 2020 Oct; 43(10):2349-2354. PubMed ID: 32461211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of CGM-Derived Metric, the Glucose Management Indicator, to Assess Glycemic Control in Non-White Individuals With Diabetes.
    Toschi E; Michals A; Adam A; Davis D; Atakov-Castillo A; Slyne C; Munshi M
    Diabetes Care; 2021 Dec; 44(12):2787-2789. PubMed ID: 34635503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comment on "The pros and cons of continuous glucose monitoring for patients with type 1 diabetes on multiple daily injections of insulin". Authors' reply.
    Petrizzo M; Maiorino MI; Esposito K
    Endocrine; 2018 Apr; 60(1):197. PubMed ID: 29404902
    [No Abstract]   [Full Text] [Related]  

  • 13. Response to Letter by Seibold regarding "Glycemic Variability and Hypoglycemic Excursions With Continuous Glucose Monitoring Compared to Intermittently Scanned Continuous Glucose Monitoring in Adults With Highest Risk Type 1 Diabetes".
    Oliver N; Avari P; Reddy M
    J Diabetes Sci Technol; 2020 May; 14(3):697-698. PubMed ID: 32052652
    [No Abstract]   [Full Text] [Related]  

  • 14. Personal Glycation Factors and Calculated Hemoglobin A1c for Diabetes Management: Real-World Data from the Diabetes Prospective Follow-up (DPV) Registry.
    Xu Y; Grimsmann JM; Karges B; Hofer S; Danne T; Holl RW; Ajjan RA; Dunn TC
    Diabetes Technol Ther; 2021 Jun; 23(6):452-459. PubMed ID: 33395370
    [No Abstract]   [Full Text] [Related]  

  • 15. Understanding the clinical implications of differences between glucose management indicator and glycated haemoglobin.
    Gomez-Peralta F; Choudhary P; Cosson E; Irace C; Rami-Merhar B; Seibold A
    Diabetes Obes Metab; 2022 Apr; 24(4):599-608. PubMed ID: 34984825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the relationship between glycated hemoglobin A1c and mean glucose levels derived from the professional continuous flash glucose monitoring system.
    Yamada M; Okada S; Oda H; Nakajima Y; C Bastie C; Kasai Y; Osaki A; Shimoda Y; Shibusawa R; Uehara R; Saito T; Ozawa A; Yamada E
    Endocr J; 2020 May; 67(5):531-536. PubMed ID: 32023560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved Estimation of Glycated Hemoglobin from Continuous Glucose Monitoring and Past Glycated Hemoglobin Data.
    Chrzanowski J; Michalak A; Łosiewicz A; Kuśmierczyk H; Mianowska B; Szadkowska A; Fendler W
    Diabetes Technol Ther; 2021 Apr; 23(4):293-305. PubMed ID: 33112161
    [No Abstract]   [Full Text] [Related]  

  • 18. Continuous glucose monitoring in primary care practice: Beside numbers.
    Bralić Lang V; Baretić M
    Prim Care Diabetes; 2021 Dec; 15(6):1113. PubMed ID: 34593346
    [No Abstract]   [Full Text] [Related]  

  • 19. Critical discrepancy in blood glucose control levels evaluated by glycated albumin and estimated hemoglobin A1c levels determined from a flash continuous glucose monitoring system in patients with type 2 diabetes on hemodialysis.
    Ushigome E; Matsusaki S; Watanabe N; Hashimoto T; Nakamura N; Fukui M
    J Diabetes Investig; 2020 Nov; 11(6):1570-1574. PubMed ID: 32356596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous Glucose Monitoring for Type 2 Diabetes: How Does It Compare with Type 1 Diabetes?
    Beck RW; Bergenstal RM
    Diabetes Technol Ther; 2022 Mar; 24(3):153-156. PubMed ID: 34569811
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.